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Patients with Pathologically Proven Renal Disease
Have Similar Declines in Renal Function Following
Robot-Assisted Partial Nephrectomy
Jonathan M. Mobley, MD, Eric H. Kim, MD, Jeffrey A. Larson, MD, Robert S. Figenshau, MD,
Joel M. Vetter, MS, Michael Hiroshi Johnson, MD, and Sam B. Bhayani, MD
Abstract
Objective: To determine if patients with pathological, medical renal disease, defined as evidence of pathological
abnormalities indicative of renal damage in the non-neoplastic partial nephrectomy specimens, have worsened
functional outcomes following robot-assisted partial nephrectomy (RPN).
Materials and Methods: Sixty patients with and 101 without pathologically proven renal disease on non-
neoplastic renal specimens were evaluated for differences in postoperative outcomes following RPN. Multiple
linear regression modeling assessed for factors influencing early and late declines in renal function.
Results: The two groups were similar in all preoperative parameters. Both patients with and without patho-
logical renal disease had similar lengths of hospitalization, transfusions, and complication rates. The percent
change in the glomerular filtration rate was similar for patients with and without pathological renal disease
( - 8.8% vs - 12.2%, p= 0.194). Patients with pathological renal disease had less chronic kidney disease (CKD)
upstaging than patients without renal disease (18.3% vs 39.6%, p = 0.006). Increasing age ( p= 0.030) and
higher preoperative glomerular filtration rates ( p= 0.044) predicted worse late percentage declines in renal
function, while increased warm ischemia time predicted late CKD upstaging ( p= 0.043).
Conclusion: The presence of pathological renal disease in non-neoplastic renal tissue did not place patients at
risk for worsened postoperative complications or renal function deterioration following RPN.
Introduction
The desire to decrease renal loss following a partialnephrectomy (PN) has led to investigations into factors
impacting the final renal function. Go and colleagues found
that as the estimated glomerular filtration rate (eGFR) de-
clined below 60mL/minute/1.73m2, the risks of cardiovas-
cular events, hospitalization, and death incrementally
increased.1 Patient factors such as body–mass index (BMI),
Charlson comorbidity index (CCI), tumor size and com-
plexity, and preoperative eGFR affect postoperative renal
function, while operative factors such as surgical approach,
estimated blood loss (EBL), type and length of ischemia, and
percentage of renal parenchyma preserved also influence the
final renal function.2–9 Mir and colleagues theorized that all
these factors affect the final renal function through one of
the two pathways: the loss of functional renal parenchyma
through excision and renorrhaphy reconstruction or incom-
plete recovery of nephrons due to ischemia.7
The effect of renal ischemia on patients with chronic
kidney disease (CKD) compared with patients with normal
renal function has recently been challenged.10,11 Although a
lower preoperative eGFR places patients at higher risk of
CKD following a PN due to lower starting points, two recent
publications found that patients with baseline CKD (preop-
erative eGFR < 60mL/minute/1.73m2) actually had de-
creased deterioration in the eGFR and less CKD upstaging
than patients with eGFRs > 60mL/minute/1.73m2 following
robot-assisted partial nephrectomy (RPN).2–4,8,10,11
Therefore, the goal of this study was to compare the
functional outcomes of patients with or without pathological,
medical renal disease after RPN.
Materials and Methods
A retrospective review of our Internal Review Board-
approved RPN database identified 623 RPN procedures per-
formed, between June 2007 and May 2013, by one of the
two surgeons, Sam B. Bhayani or Robert S. Figenshau. An
RPN procedure was performed as previously described.12,13
From the total RPNs, we identified 249 cases where the non-
neoplastic renal tissue was examined. A total of 161 procedures
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were included in this study after the following exclusions: 31
missing RENAL nephrometry scores,14 53 missing follow-up
creatinine levels, and 4 multiple renal cell carcinoma resec-
tions in the same patient.
Demographic and perioperative variables collected in-
cluded age, gender, race, BMI, American Society of An-
esthesiologists (ASA), CCI, presence of diabetes mellitus
(DM) or hypertension (HTN), creatinine levels, tumor size,
RENAL nephrometry scores, solitary kidney status, ap-
proach, clamp status, operative time, warm ischemia time
(WIT), EBL, transfusion rate, complications, and length of
stay. Complications were categorized based on the Clavien
classification system.15 The Modification of Diet in Renal
Disease equation was used for eGFR calculations.16 CKD
staging was stratified by the definitions set by the National
Kidney Foundation.17 Pathology reports were reviewed, and
patients with non-neoplastic renal parenchyma containing
glomerulosclerosis, arteriosclerosis, tubular atrophy, or in-
terstitial fibrosis were labeled as having pathologically pro-
ven medical renal disease (PRD).
The change in renal function 1 year following RPN was
compared between patients with and without PRD in two
separate comparisons. The first comparisons were performed
on the entire population (n = 161). To minimize differences in
tumor size and complexity, a second analysis was performed
on 39 matched pairs with similar gender, age (within 10
years), race (African-American or other), tumor size (within
2 cm), RENAL nephrometry score (within 1 point), clamped
status (clamped vs off-clamp), and timing of postoperative
creatinine (within 90 days). Multiple linear regression mod-
eling was used to independently evaluate factors related to
early (1–4months) and late (9–18months) changes in percent
eGFR and CKD upstaging. Variables included in the model
were age, gender, ASA, DM, HTN, tumor size, RENAL
nephrometry score, preoperative eGFR, WIT, and presence
of PRD.
Continuous variables were compared using the two-sided
t-test, assuming nonequal variance, while categorical vari-
ables were compared using the chi-square test of indepen-
dence or Fisher’s exact test (if n < 5). For matched analysis,
paired t-test and McNemar’s test were used for numeric and
binary categorical data, respectively. All tests were per-
formed two sided with statistical significance set as p < 0.05.
All analyses were performed using R statistical software
(R Development Core Team, version 2.15.1).
Results
Baseline patient and tumor characteristics are presented
in Table 1. Patients were divided based on the presence of
PRD on pathologic evaluation of non-neoplastic renal tis-
sue (101 with no PRD and 60 with PRD). As expected,
and compared to those with no PRD, a greater proportion of
patients with PRD were diagnosed with HTN ( p = 0.161) and
DM ( p = 0.063), had higher mean serum creatinine ( p =
0.079), lower eGFR ( p = 0.120), and were more likely to be
categorized as the CKD stage 3/4 ( p = 0.169). Analysis of
the matched subset of 39 pairs resulted in similar preopera-
tive renal function, but the patients with PRD had more DM
( p = 0.02) and HTN ( p= 0.059).
Perioperative outcomes for the full data set and matched
cohorts are presented in Table 2. The patients with PRD had
similar increases in creatinine and percent declines in eGFR
following RPN, but were less likely to experience an in-
crease in CKD stage ( p = 0.006). Among the matched groups,
there was no difference in functional outcomes between the
groups.
Multiple linear regression analysis found that increasing
patient age ( p = 0.030) and preoperative eGFR ( p = 0.044)
predicted greater eGFR percentage decline in the late post-
operative period, while DM ( p= 0.066) and higher WIT
( p = 0.083) neared significance (Table 3). Higher preopera-
tive eGFR ( p= 0.068) and the absence of PRD ( p = 0.071)
showed trends toward early CKD upstaging (Table 4). In-
creased WIT predicted CKD upstaging in the late postoper-
ative period ( p= 0.043), and the presence of HTN approached
significance ( p= 0.055).
Discussion
The single-institution study by Guillotreau and colleagues
demonstrated a strong relationship between preoperative
eGFR < 60mL/minute/1.73m2 and preservation of renal
function after RPN. Median change in eGFR for patients with
CKD was less than in those with normal baseline renal
function ( - 5% vs - 12%, p = 0.004). The proportion of
patients with normal baseline renal function experiencing a
single increase in the CKD stage was greater than in those
with preoperative CKD (34% vs 12%, p = 0.001).11 A multi-
institutional study confirmed the relationship between pre-
operative CKD and preservation of renal function following
RPN.10 The mean change in eGFR was found to be less in
those with preoperative CKD (- 2.8 vs - 9.1mL/minute/m2,
p = 0.017) and fewer of these patients experienced CKD up-
staging (12% vs 33%, p < 0.001).10
In the present study, pathologic findings of renal disease
were identified in 37% of patients undergoing RPN. These
patients were more likely to have a higher CKD stage (28%
vs 17%; CKD stage 3/4), although this was not significant. In
agreement with the above-discussed studies, patients with
PRD were less likely to experience CKD upstaging follow-
ing RPN (18% vs 40%, p = 0.006).10,11 There was a dimin-
ished mean decline in percentage eGFR for patients with
PRD, but it was not statistically significant (- 9% vs - 12%,
p = 0.194). These findings were important, since they show
that the kidneys of patients with PRD recover the same as
nondiseased kidneys following the ischemic insults of RPN.
The impact of PRD on renal function following RPN did not
appear to be independent of baseline renal function. In the
present study, once matched by tumor characteristics, sur-
gical approach, and demographics (including baseline renal
function), the change in eGFR and proportion of patients
experiencing CKD upstaging following RPN were not dif-
ferent based on the presence of PRD. To further support this
concept, the multivariate analysis did not show the presence
of PRD predictive of either eGFR changes or CKD upstaging,
although the study may have been underpowered to find PRD
protective of CKD upstaging.
In our patient cohort, none of the variables analyzed were
predictive of eGFR decline in the early postoperative period.
Statistically significant late predictors of renal functional loss
were found to be increasing age and increasing preoperative
eGFR. Again, the finding of a higher preoperative eGFR re-
sulting in greater percentage declines in renal function further
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supports the findings of the two previously mentioned stud-
ies.10,11 Multivariate analysis found no significant predictor
of early CKD upstaging; however, there was a trend toward
CKD upstaging with a higher preoperative eGFR ( p = 0.068)
and the absence of PRD ( p= 0.071). The lack of significance
is likely due to insufficient power, and these two factors again
suggest an inverse relationship between preoperative renal
insufficiency and postoperative CKD upstaging.10,11 A pro-
tective role of lower preoperative eGFR ( p = 0.177) and the
presence of PRD ( p = 0.117) for CKD upstaging were less
evident in the late postoperative period, but the presence of
HTN ( p = 0.055) and lower WITs ( p= 0.043) appeared to
have greater protection from CKD upstaging.
As discussed by Kumar and colleagues, the apparent pro-
tective effect of CKD on renal function following RPN may
be a result of confounding factors by the surgeon. Knowledge
of baseline CKD may lead the surgeon to consider technical
changes that will maximize renal function preservation: re-
ducing WIT and/or minimizing renal volume excised.4,10,18
In the present study, mean WIT and utilization of the off-
clamp technique were not significantly different between
PRD and no PRD groups. Differences in renal volume ex-
cised were likely insignificant given the similar tumor size,
nephrometry score, and surgical margin rates between
groups. Also, in this study, any adjustment of resection vol-
umes per surgeon would have to be based solely on the
presence of HTN or DM, since the preoperative renal func-
tion was similar between groups and the presence of PRDwas
unknown before surgery.
In contrast to our findings, Lifshitz and colleagues report
that the presence of arteriosclerosis in the non-neoplastic
pathology specimens was predictive of late eGFR decline
independent of the baseline eGFR.5 The study methodology
may be responsible for this contradiction. Lifshitz and col-
leagues separated those with arteriosclerosis, glomerulo-
sclerosis, and interstitial fibrosis/tubular atrophy and also
quantified each abnormality.5 In the present study, as the
number of patients with each specific pathologic feature of
renal disease was limited, all patients with PRD were com-
bined for analysis. The surgical approach between our study
and that of Lifshitz and colleagues was different as well.
Lifshitz and colleagues describe a laparoscopic PN technique
with artery-only clamping in 17% of patients, renal hypo-
thermia applied in 23% of cases, and median WIT of 31
minutes.5 In this study, the procedures were RPNwith 19% of
procedures performed off-clamp and median WIT of 17
Table 1. Pathological, Demographic, and Tumor Characteristics of Patients Undergoing
Robot-Assisted Partial Nephrectomy
Full data set Matched set
Variable No PRD, n = 101 PRD, n = 60 p-Value No PRD, n = 39 PRD, n = 39 p-Value
Age, mean (SD) 58.2 (12.2) 60.4 (9.9) 0.224 59.6 (9.5) 59.7 (9.6) 0.934
Gender, male, n (%) 53 (52.5) 33 (55.0) 0.756 29 (51.2) 29 (51.2) 1.000
Race, n (%)
White 86 (85.1) 52 (86.7) 0.456 37 (94.8) 36 (92.3) 0.840
Black 14 (13.9) 6 (10.0) 1 (2.6) 1 (2.6)
Other 1 (1.0) 2 (3.3) 1 (2.6) 2 (5.1)
BMI, mean (SD) 30.4 (7.45) 29.8 (5.5) 0.529 28.3 (4.8) 29.8 (5.1) 0.175
HTN, n (%) 56 (55.4) 40 (66.7) 0.161 20 (51.2) 28 (71.8) 0.059
DM, n (%) 19 (18.8) 19 (31.7) 0.063 3 (7.6) 11 (28.2) 0.021
ASA score, n (%)
1 1 (1.0) 2 (3.3) 0.343 1 (2.6) 2 (5.1) 0.204
2 56 (56.0) 27 (45.0) 25 (64.1) 18 (46.2)
3 42 (42.0) 31 (51.7) 11 (30.6) 19 (48.7)
4 1 (1.0) 0 (0.0) 1 (2.6) 0 (0.0)
CCI
0–1 71 (70.3) 38 (63.3) 0.472 27 (69.2) 27 (69.2) 0.920
2 15 (14.9) 13 (21.7) 6 (15.4) 7 (17.9)
‡ 3 15 (14.9) 11 (18.3) 6 (15.4) 5 (12.8)
Tumor size, cm, mean (SD) 2.83 (1.44) 2.51 (1.17) 0.136 2.68 (1.25) 2.43 (1.13) 0.341
RENAL score, mean (SD) 7.59 (1.87) 7.55 (1.52) 0.871 7.90 (1.55) 7.85 (1.42) 0.880
Solitary kidney n (%) 1 (1.0) 1 (1.7) 1.000 1 (2.6) 0 (0.0) 1.000
Preoperative serum creatinine, mean (SD) 0.92 (0.27) 1.02 (0.35) 0.079 0.95 (0.28) 0.96 (0.33) 0.833
Preoperative eGFR, mean (SD) 82.7 (24.4) 76.1 (26.5) 0.120 77.4 (22.1) 78.2 (26.7) 0.892
CKD 1 39 (38.6) 16 (26.7) 0.169 11 (28.2) 11 (28.2) 1.000
CKD 2 45 (44.6) 27 (45.0) 19 (48.7) 18 (46.2)
CKD 3 17 (16.8) 16 (26.7) 9 (23.1) 10 (25.6)
CKD 4 0 (0.0) 1 (1.7) 0 (0.0) 0 (0.0)
Glomerulosclerosis 0 (0.0) 34 (56.7) 0 (0.0) 21 (53.8)
Arteriosclerosis 0 (0.0) 34 (56.7) 0 (0.0) 24 (61.5)
Tubular atrophy/interstitial fibrosis 0 (0.0) 5 (8.3) 0 (0.0) 4 (10.3)
Statistically significant values are highlighted in bold.
ASA =American Society of Anesthesiologists; BMI= body–mass index; CCI=Charlson comorbidity index; CKD = chronic kidney
disease stage; DM = diabetes mellitus; eGFR = estimated glomerular filtration rate; HTN = hypertension; PRD = pathologically proven
medical renal disease; SD = standard deviation.
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minutes. It is impossible to discern how these multiple dif-
ferences in study factors resulted in opposing conclusions
regarding the eGFR decline following PN in patients with
PRD.
CKD, specifically an eGFR < 60mL/minute/1.732, places
patients undergoing a PN at increased risk of complications
and longer hospitalization.10,11,19 Herein, the length of hos-
pitalization and complication rates were similar for both
patients with and without PRD, but the two groups had less
differences in baseline renal function than both previous
studies.10,11 Also, in this study, only 28% of the PRD group
had an eGFR < 60mL/minute/1.732.
Table 2. Perioperative and Functional Outcomes for Patients Following Robot-Assisted
Partial Nephrectomy
Full data set Matched set
Variable No PRD, n = 101 PRD, n = 60 p-Value No PRD, n = 39 PRD, n= 39 p-Value
Off clamp, n (%) 18 (17.8) 12 (20.0) 0.731 4 (10.3) 4 (10.3) 1.000
EBL, mL, mean (SD) 159.9 (168.9) 175.5 (159.9) 0.558 148.7 (138.7) 173.8 (149.1) 0.443
OR time, minute, mean (SD) 156.4 (49.8) 154.9 (50.5) 0.858 149.1 (42.8) 158.6 (54.6) 0.398
WIT, minute, mean (SD) 16.7 (11.3) 17.1 (11.6) 0.822 17.6 (9.4) 18.8 (10.4) 0.588
LOS, days, n (%) 2.4 (1.1) 2.4 (1.0) 0.969 2.4 (0.9) 2.4 (1.0) 0.813
Transfusion, n (%) 2 (2.0) 1 (1.7) 0.887 0 (0.0) 1 (2.6) 1.00
Complications, n (%)
All 9 (8.9) 6 (10.0) 0.818 5 (12.8) 4 (10.3) 0.739
Clavien 1&2 4 (4.0) 4 (6.7) 0.675 1 (2.6) 3 (7.7) 0.315
3 5 (5.0) 2 (3.3) 4 (10.3) 1 (2.6)
4 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Positive margin, n (%) 5 (5.2) 2 (3.5) 0.636 1 (2.8) 2 (5.3) 1.00
Preoperative eGFR, mean (SD) 82.7 (24.4) 76.1 (26.5) 0.120 77.4 (22.1) 78.2 (26.7) 0.892
Postoperative eGFR,a mean (SD) 71.8 (22.2) 68.2 (23.6) 0.348 67.9 (19.1) 69.8 (23.5) 0.697
Change in creatinine, mean (SD) 0.12 (0.15) 0.10 (0.17) 0.365 0.12 (0.17) 0.12 (0.18) 0.666
% Change in eGFR,a % (SD) - 12.2 (14.6) - 8.8 (16.4) 0.194 - 11.1 (0.16) - 9.3 (0.17) 0.584
CKD upstaging, n (%) 40 (39.6) 11 (18.3) 0.006 9 (23.1) 4 (10.3) 0.165
Statistically significant value is highlighted in bold.
aPostoperative eGFR levels are based on creatinine levels drawn nearest to 1 year postoperative.
EBL = estimated blood loss; OR = operative; WIT =warm ischemia time; LOS = length of stay.
Table 3. Early and Late Predictors of Estimated Glomerular Filtration Rate Percent Changes
Following Robot-Assisted Partial Nephrectomy
Predictor Estimate Standard error p-Value
Early (1–4 months) (n = 49)
Age - 0.003 0.002 0.231
Gender, male 0.018 0.043 0.669
ASA - 0.003 0.046 0.948
Diabetes - 0.032 0.051 0.537
Hypertension 0.061 0.056 0.286
Preoperative eGFR 0.001 0.017 0.409
Tumor size (cm) 0.006 0.019 0.752
RENAL score - 0.015 0.017 0.404
Warm ischemia time 0.001 0.003 0.580
PRD - 0.064 0.045 0.164
Late (9–18 months) (n = 64)
Age 0.004 0.002 0.030
Gender, male 0.012 0.039 0.762
ASA 0.013 0.037 0.721
Diabetes 0.095 0.051 0.066
Hypertension 0.007 0.042 0.870
Preoperative eGFR 0.002 0.001 0.044
Tumor size (cm) - 0.008 0.016 0.607
RENAL score 0.013 0.012 0.258
Warm ischemia time 0.004 0.002 0.083
PRD - 0.047 0.043 0.281
Statistically significant values are highlighted in bold.
ASA=American Society of Anesthesiologists.
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Limitations to our study include single institution, small
study population, and retrospective analysis. As our cohort
represents a limited number of patients undergoing RPN with
postoperative non-neoplastic tissue evaluation, the effect of
variability in patient, tumor, and perioperative characteristics
was likely more pronounced. In addition, our study was likely
underpowered to detect statistically significant relationships,
particularly for our matched-pair subset analysis. The retro-
spective study design further reduced our study population as
patients were excluded due to omitted preoperative clinic
characteristics. As PRD relied on the careful examination of
pathologists of small volumes of non-neoplastic tissue in-
cluded with the PN specimen, the prospective study design
may more accurately diagnose PRD and better quantify the
extent of PRD. Next, our analysis demonstrates the effects of
RPN on both patients with and without PRD who are sub-
jected to relatively low WIT. It is unknown if these findings
are relevant in cases involving longer WIT. Finally, a volu-
metric analysis of excised and preserved renal tissue was not
available in this study, which might clarify the potential
differences in surgical techniques between the two groups
and alter the predictive factors.4,6,7
Conclusions
The present study found similar complication rates and
declines in the eGFR in patients with PRD compared to those
without PRD following RPN. Concomitantly, there was a di-
rect relationship between the higher baseline eGFR and per-
cent eGFR deterioration consistent with the findings in other
studies.10,11 The PRD group experienced significantly less
CKD upstaging. Further studies with a larger number of non-
neoplastic RPN specimens are needed to determine if PRD
provides a protective role in eGFR decline following RPN.
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